Avitus Orthopaedics gets investment from Connecticut Innovations

Avitus Orthopaedics Inc. recently announced that they received a $350,000 investment from Connecticut Innovations. The investment will be used to help Avitus relocate its headquarters to Connecticut as well as finalize the product manufacturing process for a disposable minimally invasive bone graft harvesting device that is currently in development. Connecticut Innovations’ funds will also go towards preparing FDA clearance filings and funding marketing initiatives to aid pilot sales.

“Avitus was established with the mission of developing new orthopedic technologies that improve clinical outcomes while decreasing health care costs compared to current procedures and devices,” Neil Shah, chief executive officer of Avitus, stated in a company press release. “This surgical device will allow surgeons to use the gold standard material for bone grafts, help to increase the efficacy and safety of the process, and decrease the overall cost.”

“The area of orthopedics is poised for growth and Avitus has demonstrated the ability to develop an innovative tool that will improve results and lower costs for hospitals,” Patrick O’Neill, director of investments at Connecticut Innovations, stated in the release. “We were delighted to attract such a high level of talent from Johns Hopkins and look forward to supporting the efforts of the organization as they bring their product to market.”